4
Changes in Ownership
Vivos Therapeutics, Inc. Filed Acc 0001493152-22-005660
Options or other derivatives
- Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Amman Bradford K. Chief Financial Officer | 2022-02-25 | Grant or award · Stock Option (Right to Buy) | +50,000 | $3.27 | $163,500 | 50,000 | D |
Loading xslF345X03/ownership.xml…